Mabion SA (DE:272)

FRANKFURT:272

272

Mabion SA

RESEARCH TOOLSreports

Compare Mabion SA (272) vs. Competitors

0 Followers

Comparison Results

272

Mabion SA

€1.85

€32.11M

-3.23

-8.10%

―

Ryvu Therapeutics SA

zł27.65

zł544.48M

-6.19

-7.47%

―

Scope Fluidics SA

zł137.00

zł436.59M

-6.98

-27.09%

―

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

zł3.62

zł275.43M

-10.03

-17.48%

―

Captor Therapeutics SA

zł42.20

zł448.71M

-4.87

143.37%

―

OncoArendi Therapeutics SA

zł5.45

zł112.29M

-8.61

-35.35%

―

xxxxxxxxxxxxx

272 vs MOC

xxxxxxxxxxxxx

Performance Comparison

DE:272

Mabion SA

1.96

-0.13

-6.35%

PL:RVU

Ryvu Therapeutics SA

23.55

-0.95

-3.88%

PL:SCP

Scope Fluidics SA

137.80

-45.20

-24.70%

PL:SVE

Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.

3.64

-0.74

-16.82%

PL:CTX

Captor Therapeutics SA

80.80

48.80

152.50%

PL:MOC

OncoArendi Therapeutics SA

5.45

-2.60

-32.30%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >